A Study to Determine Safety and Immunogenicity of the Candidate COVID-19 Vaccine AZD1222 Delivered by Aerosol in Healthy Adult Volunteers

NCT05007275 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Covid19
SARS-CoV-2 Infection

Interventions

BIOLOGICAL: 1x10^9 vp AZD1222
BIOLOGICAL: 5x10^9 vp AZD1222
BIOLOGICAL: 1x10^10 vp AZD1222

Sponsor

Imperial College London

Collaborators

[object Object]
[object Object]